Decisions of the Extraordinary General Meeting of Brighter AB.
Brighter AB (publ), reg. no. 556736-8591, has held an Extraordinary General Meeting on Friday 16 December 2016 to approve the distribution of parts of its shares in Camanio Care AB to Brighter's shareholders.
DECISIONS OF THE MEETING
Decisions on the distribution of shares in Camanio Care AB (formerly Brighter Two AB)
The Board of Directors decided on a dividend to shareholders of Brighter consisting of a part of Brighter's shares Camanio Care AB, namely 1,733,672 shares.
The decision means that shareholders of Brighter receive one (1) share in Camanio Care for every thirty (30) shares in Brighter. The proportion of shares in Camanio Care owned by Brighter, which will be distributed, has, as of December 15, 2016, a recorded book value of SEK 4,596,277.08 (equivalent value for Brighter Two AB before the merger, recorded in the annual report for 2015 was 4,576,946.88), corresponding to a dividend of SEK 0.08837266028 per share in Brighter. In the event that a shareholder's holding in Brighter is not evenly divisible by thirty (30) fractions of a share in Camanio Care, such fractions of shares will be consolidated into whole shares which will be sold and the proceeds from the sale will be paid to the shareholders by Euroclear Sweden AB.
The Board is authorized to determine the record date in coordination with Euroclear, however, that payment must be made within one month from the date of this Extraordinary Shareholders Meeting, ie by January 16, 2016.
For more information, please contact:
Truls Sjöstedt, CEO
Tel: +46 709 73 46 00
Email: truls.sjostedt@brighter.se
Henrik Norström, COO
Tel: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
About Brighter AB.
Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first launch Actiste®, the company creates a more efficient care chain with focus on the individual. The goal is to simplify, streamline and enhance the information flow of relevant and reliable data between the patient and health care professionals. Brighter is initially focused on diabetes care and care for the elderly, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.
The Company's shares are listed on NASDAQOMX FIRST NORTH/BRIG. Brighter's Certified Adviser is Remium Nordic AB, +46 (0)8 454 32 50, CorporateFinance@remium.com , www.remium.com .
This information is information that Brighter AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 14:30 CET on December 16 2016.